Skip to content

Clinical trials

Phase 4 Schizophrenia trials in the United Kingdom

Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.

Filters: Condition: Schizophrenia Phase: Phase 4 Country / region: United Kingdom Clear all

16 trials match Source: ClinicalTrials.gov registrations

Trials started per year

By phase, 2000 to 2026.

Trials started per year
CategoryTrials
20011
20021
20041
20053
20061
20101
20113
20121
20151
20161
20181
20241

Status

Trials by registry status. Select a bar to filter.

Trials by status
CategoryTrials
Completed13
Terminated2
Recruiting1

Top lead sponsors

A sponsor with a page on Pharma Observatory links to it.

Top lead sponsors
CategoryTrials
Otsuka Pharmaceutical Development & Commercialization, Inc.3
AstraZeneca2
Imperial College London2
Dr. Inge Winter1
Eli Lilly and Company1
Institute of Psychiatry, London1
Janssen Pharmaceutica N.V., Belgium1
Janssen-Ortho Inc., Canada1
Rene Kahn1
UMC Utrecht1

Top conditions

MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.

Top conditions
CategoryTrials
Schizophrenia16
Psychotic Disorders4
Alzheimer Disease1
Schizophrenia, Paranoid1

Trials

Showing 1 to 16 of 16. Each trial links to its page on Pharma Observatory.

Recently changed trials

Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.

No changes to these trials in the last 7 days.

Go deeper on Pharma Observatory

Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.